Increased fibrinolytic potential after diet intervention in healthy coronary high-risk individuals.

Twenty healthy individuals (15 men and 5 women) with initial fasting serum triglycerides greater than or equal to 1.80 mmol/l and euglobulin clot lysis time after venous occlusion greater than or equal to 60 min (upper normal limit 45 min) were tested for fibrinolytic response to venous occlusion and intravenous injection of desmopressin (DDAVP), serum lipids, serum glucose and relative body weight before and after a minimum of 3 to a maximum of 12 months' diet intervention. In order to be defined as a good diet responder, at least 20% reduction of the initial serum triglyceride concentration was required. At the end of the study, half of the participants (7 men and 3 women) met the criteria of good diet responders. All of these showed an improved fibrinolytic response to DDAVP injection, and 7 out of 10 had a normalized fibrinolytic response to venous occlusion. We conclude that, through dietary measures with substantial reduction of hypertriglyceridaemia, it is possible to improve and even normalize the fibrinolytic potential.

[1]  I. Hjermann,et al.  Hyperlipoproteinaemia and reduced fibrinolytic activity in healthy coronary high-risk men. , 2009, Acta medica Scandinavica.

[2]  H. Arnesen,et al.  The euglobulin clot lysis time, a rapid and sensitive method for the assay of fibrinolytic activity after venous stasis. , 2009, Scandinavian journal of haematology.

[3]  I. Nilsson,et al.  A family with thromboembolic disease associated with deficient fibrinolytic activity in vessel wall. , 2009, Acta medica Scandinavica.

[4]  P. Andersen.  Hyperlipidaemia and reduced fibrinolytic activity associated with thromboembolic complications in a family. , 2009, Acta medica Scandinavica.

[5]  S. Thompson,et al.  HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY , 1986, The Lancet.

[6]  M. Blombäck,et al.  Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. , 1985, The New England journal of medicine.

[7]  F. España,et al.  Reduced fibrinolytic activity in coronary heart disease in basal conditions and after exercise. , 1985, Thrombosis research.

[8]  L. Tengborn,et al.  Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor. , 1985 .

[9]  L. Carlson,et al.  Serum triglycerides--an independent risk factor for myocardial infarction but not for angina pectoris. , 1985, The New England journal of medicine.

[10]  M. Blombäck,et al.  The role of the fibrinolytic system in deep vein thrombosis. , 1985, The Journal of laboratory and clinical medicine.

[11]  A. Skjennald,et al.  Venous Thrombosis Following Diagnostic Transvenous Catheterization by Percutaneous Catheter Insertion: An Evaluation of Desmopressin as a Thromboprophylactic Agent , 1984, Thrombosis and Haemostasis.

[12]  I. Holme,et al.  Serum glucose levels during long-term observation of treated and untreated men with mild hypertension. The Oslo study. , 1984, The American journal of medicine.

[13]  F. Bachmann,et al.  Tissue Plasminogen Activator: Chemical and Physiological Aspects , 1984, Seminars in thrombosis and hemostasis.

[14]  T. Meade,et al.  HYPERTRIGLYCERIDAEMIA AND HYPERCOAGULABILITY , 1983, The Lancet.

[15]  Gevers Leuven Ja,et al.  Response to fibrinolytic activity and factor VIII-related antigen to stimulation with desmopressin in hyperlipoproteinemia. , 1982 .

[16]  I. Holme,et al.  EFFECT OF DIET AND SMOKING INTERVENTION ON THE INCIDENCE OF CORONARY HEART DISEASE Report from the Oslo Study Group of a Randomised Trial in Healthy Men , 1981, The Lancet.

[17]  T. Meade,et al.  Effect of treatment of hyperlipidaemia on haemostatic variables. , 1980, British medical journal.

[18]  R. Bawol,et al.  Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease. , 1980, The New England journal of medicine.

[19]  S. Thompson,et al.  HÆMOSTATIC FUNCTION AND CARDIOVASCULAR DEATH: EARLY RESULTS OF A PROSPECTIVE STUDY , 1980, The Lancet.

[20]  T. Lawrie,et al.  Disordered "fibrinolytic potential" in coronary heart disease. , 1977, Thrombosis research.

[21]  Maddocks Ac.  Letter: Sterilisation of cardiac bioptome. , 1974 .

[22]  D. Wilmore,et al.  Fat boys get burned. , 1972, Lancet.

[23]  S. Epstein,et al.  Impaired fibrinolytic response to exercise in patients with type-IV hyperlipoproteinaemia. , 1970, Lancet.

[24]  C. Exley.  THE GENERAL PRACTITIONER AND THE MATERNITY SERVICE , 1924 .

[25]  I. Nilsson,et al.  Defective fibrinolysis in blood and vein walls in recurrent "idiopathic" venous thrombosis. , 1972, Acta chirurgica Scandinavica.